Rise in Prevalence of Chronic & Acute Injuries to Drive Global Negative-pressure Wound Therapy (NPWT) Devices Market

 

Negative Pressure Wound Therapy (NPWT) Devices 

Negative pressure wound therapy, also referred to as vacuum assisted wound closure, is used to heal wounds and drain fluids from the wound site. Pressure ulcers, diabetic ulcers, skin flaps, and other wounds can all be treated with negative pressure wound therapy.

In the upcoming years, there will likely be a significant increase in the burden of both chronic and acute injuries worldwide. The National Center for Biotechnology Information estimates that more than 2.5 million Americans suffer from pressure ulcers each year. Over 700,000 patients in the U.K. suffer from pressure ulcers each year, and 180,000 of those cases are brand-new ones, according to the National Health Service (NHS). Another significant indication for negative-pressure wound therapy (NPWT) devices is diabetic foot ulcers. During the forecast period, an increase in the number of patients with diabetic foot ulcers is likely to propel the Negative-pressure Wound Therapy (NPWT) Devices Market.

According to the National Center for Biotechnology Information, the annual incidence of diabetic foot ulcers globally is between 9.1 million and 26.1 million. Around 15% to 25% of patients with diabetes mellitus develop diabetic foot ulcer during their lifetime. The geriatric population is more prone to chronic & acute injuries and diabetic foot ulcers. Surge in geriatric population in developed as well as developing countries is likely to propel the negative-pressure wound therapy (NPWT) devices market during the forecast period.